Teva stops testing its migraine drug as cluster headache treatment

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment was unlikely to meet the main goal of a late-stage trial.

Source: Reuters: Health - April 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news